Latest News

Reshaping Breast Cancer Surgery and Minimizing Radical Treatment Approaches
Reshaping Breast Cancer Surgery and Minimizing Radical Treatment Approaches

August 14th 2025

Tran Ho, DO, FSSO, FACS, discussed how she found her passion in breast surgical oncology and how her mentors helped her achieve success.

FLEX study findings show that the MammaPrint Index was predictive of 5-year DRFI for endocrine therapy with or without chemotherapy in early breast cancer.
MammaPrint Displays Predictive Utility for Chemo in HR+/HER2– Breast Cancer

August 13th 2025

Obesity and weight gain are associated with adverse outcomes following breast cancer diagnosis.
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer

August 12th 2025

The decision is based on phase 3 VERITAC-2 trial data showing a significant PFS improvement vs fulvestrant in ESR1-mutant ER+/HER2– breast cancer.
FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2– Breast Cancer

August 11th 2025

Patients reclassified to high-risk clinicopathology with DCISionRT saw an absolute reduction in IBR rates of 11.6%; from 17.7% to 6.1%.
DCISionRT Enhances DCIS Risk Stratification Beyond Clincopathology

August 6th 2025

Latest CME Events & Activities

More News